In Depth 5 Apr 2023 Antimicrobial peptides: a promising class to tackle antimicrobial resistance …the mid-20th century, and there are now more than 3,000 AMPs reported in the Antimicrobial Peptide Database (APD) originating from six life kingdoms; animals, plants, fungi, protists, archaea, and bacteria…. April 5, 2023 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 5 Mar 2024 Fourteen biotech companies with market caps exceeding $100 billion …approval of Casgevy for the treatment of sickle cell disease in the U.S., the U.K., the Kingdom of Saudi Arabia, and Bahrain. This is a milestone not only for the… March 5, 2024 - 18 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 22 Jun 2020 The Age of Agrochemicals is Ending: It’s Time for Agricultural Biotechnology …pests and pathogens come in all shapes and sizes, and from multiple kingdoms of life; not just animals such as insects, but fungi and bacteria too. This poses an enormous… June 22, 2020 - 9 minutesmins - By Farhan Mitha Share WhatsApp Twitter Linkedin Email
Best in Biotech 14 Oct 2024 Six biomimicry biotech companies harnessing nature’s wisdom to develop breakthrough drug candidates The plant and animal kingdom can help scientists study areas like extreme metabolic changes, obesity resistance, and muscle preservation, which can lead to the discovery of novel therapeutic targets and… October 14, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 8 Dec 2022 DNA repair mechanism study could boost cancer treatment …information to disease states,” Bralić said. “Through the KAUST Smart Health Initiative, we will work with clinicians in the Kingdom to study the clinical mutational landscape of NER proteins in… December 8, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Interview 9 Nov 2017 Meet the Spin-Out Queen Taking on Neurological Diseases Mary Kerr, CEO of NeRRe and Managing Director of KanDy, told us how its approaches could change the face of therapies for neuronal hypersensitivity and women’s health indications. Mary Kerr’s… November 9, 2017 - 4 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 14 Nov 2016 USB key Diagnostic could help manage HIV Treatment Anywhere A new method of gene sequencing has brought us an HIV diagnostic on a “USB stick”, which determines the levels of the virus with one drop of blood and in… November 14, 2016 - 3 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
News and Trends 22 Nov 2022 Achilles Therapeutics receives US patent for immunotherapies A U.S. patent has been granted to Achilles Therapeutics plc for the treatment of patients with an immunotherapy, including vaccine, antibody and autologous T cell therapy approaches, targeting clonal neoantigens… November 22, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 30 Jun 2025 Life sciences in Wales: biotechs in the scene in 2025 Famous for its rugged coastline and scenic mountains, Wales is also home to a thriving life science industry. Supported by science parks, med-tech companies, and universities, the country has opened… June 30, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 4 Jul 2017 British Liquid Biopsy for Ovarian Cancer Outperforms the Gold Standard The British company Angle has announced results from a large-scale trial that seem to indicate its liquid biopsy technology could surpass the gold standard in ovarian cancer diagnosis. Angle, in… July 4, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 22 Sep 2016 After only 6 months, Akarna seals the deal with Allergan for €44.8M upfront Earlier this week, we announced the launch of a new diagnostic tool for NASH by the French company Genfit. Now, Ireland strikes back with the acquisition of Akarna with a… September 22, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 28 Jun 2022 Time Partners closes £30M venture fund to back life sciences startups Time Partners Limited has announced the final closing of its first advised fund, Time Boost Capital I LP, a £30 million ($36.6 million) genomics venture fund to provide match funding… June 28, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email